Cardea Bio, Inc.
12Patents
12Active
12Granted
54Portfolio score
Filing activity: May 8, 2017 → Aug 28, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10968481B2 | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids | Performing Operations; Transporting | 7 | Active |
| US11536722B2 | Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same | Physics | 3 | Active |
| US11215580B2 | System and method for DNA sequencing and blood chemistry analysis | Electricity | 1 | Active |
| US11016088B2 | Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same | Physics | 1 | Active |
| US11732296B2 | Two-dimensional channel FET devices, systems, and methods of using the same for sequencing nucleic acids | Performing Operations; Transporting | 1 | Active |
| US11092598B2 | Chemically differentiated sensor array | Physics | 1 | Active |
| US12345677B2 | Integrated circuit with 2D FETs for direct and indirect target signal measurement | Physics | 0 | Active |
| US11056343B2 | Providing a temporary protective layer on a graphene sheet | Electricity | 0 | Active |
| US11782057B2 | Ic with graphene fet sensor array patterned in layers above circuitry formed in a silicon based cmos wafer | Physics | 0 | Active |
| US12372521B2 | Chemically differentiated sensor array | Physics | 0 | Active |
| US12298301B2 | Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same | Physics | 0 | Active |
| US11713455B2 | Enhanced selection of efficient targeted genome manipulating agents | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.